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Hyperhomocysteinemia can cause cerebral venous thrombosis. Recombinant 
tissue plasminogen activator is one of the treatment options for cerebral 
venous thrombosis in selected cases. We present here a 7-year-old boy with 
homocysteinuria with stroke. MRI of brain showed cerebral venous sinus 
thrombosis. We successfully treated with intravenous recombinant tissue 
plasminogen activator. He recovered completely without any complications. 
Recombinant tissue plasminogen activator can be considered one of the treatment 
options in cerebral venous thrombosis in homocystinura.
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Introduction 
Homocystinuria is increased homocysteine in the urine (1). Increased homocysteine 
in the blood is a risk factor for both neurovascular and cardiovascular disorders (2). 
Homocysteine level more than 50 µM is due to defects in remethylation or trans 
sulphuration. 
The estimated worldwide frequency of homocystinuria ranges from 1 case per 
58 000 to 1 case per 1000000(3). Homozygous cystathionine beta synthase 
(CBS) deficiency presents with the major clinical manifestations of premature 
arteriosclerosis, thromboembolism, mental retardation, ectopialentis, and skeletal 
abnormalities (4). 
We report a child with homocysteinuria with cerebral venous sinus thrombosis 
(CVST).
Case Report
After uneventful pregnancy and normal birth, developmentally delayed seven years 
old boy presented with fever and altered sensorium of two days duration. He was 
born from consanguineously married couple. He was on spectacles for myopia since 
early child hood. On examination, his height was more than 97th percentile (135 
cm). Supero-nasal lens subluxation with zonular dialysis was seen in both eyes. 
His Glasgow coma scale was 8/15 at the time of admission. His motor power in the 
lower limbs was 3/5(MRC grade). There were no signs of meningeal irritation.
His hemoglobin was 9 gm/dl, with normal white blood cell counts and platelets. 
His serum electrolytes, liver function and renal function tests were normal. Axial 
non contrast CT showed hemorrhagic infarcts with peri-lesional edema in bilateral 
thalami (Fig 1). Mild dilatation of lateral ventricle was noted. MRI of brain shows 
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effect of treatment was reassessed with angiogram 
at 12-hour intervals. rtPA infusion was discontinued 
after 36 hours with documentation of flow restoration 
in the deep venous system. Heparin anticoagulation 
was maintained, and converted to oral warfarin therapy 
after 96 hours. Child’s sensorium improved partially but 
hydrocephalus persisted requiring external ventricular 
drainage (EVD). After EVD, sensorium improved and 
the child recovered completely without any sequelae. 
Post thrombolytic CT showed resolution of hyperdensity 
in the internal cerebral vein & the straight sinus (Fig. 
3). He also received pyridoxine, folic acid, and vitamin 
B12 supplementation. During his 24 months follow-up 
he had no recurrence of thrombosis.
discussion
Homocystinuria is a multisystem disorder characterized 
by myopia, mental retardation, downward lens 
dislocation, seizure, and thromboembolic events (4). 
The diagnosis of homocysteinuria is based on clinical 
presentation and laboratory findings. This child 
presented with developmental delay, lens subluxation 
and altered sensorium. Investigations were suggestive of 
CVST with increased serum homocysteine. 
There has been lack of evidence for management of 
mixed signal intensity lesions in bilateral thalami in 
T2W axial image (Fig. 2a), blooming of the thalamic 
hemorrhage on GRE axial images (Fig. 2b), non filling 
of the deep venous system is noted except for a small 
segment of the straight sinus on sagittal view of TOF MR 
venogram (Fig. 2c). His initial Partial thromboplastin 
time and Prothrombin time were normal. Serum lactate, 
plasma ammonia, arterial blood gas was normal. His 
serum homocysteine (CLIA) was more than 50 µmol/l 
(normal- 4.9-15). 
Patient was monitored in pediatric intensive care. We 
started on supportive measures for increased intracranial 
pressure and CVST was suspected secondary to 
homocysteinuria in view of developmental delay, lens 
dislocation and increased homocystine levels. Parents 
were counseled about the options available including 
heparin infusion and intravenous tissue plasminogen 
activator (tPA). Parents consented for intravenous tPA 
with intravenous heparin. Un-fractionated intravenous 
heparin infusion was started after bolus. Fibrinogen and 
partial thromboplastin time were monitored every 12 
hours. 
The straight sinus was catheterized with Echelon 
micro-catheter and 2 mg of rtPA was given as bolus, 
infusion started at the rate of 2mg/h. The radiological 
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Fig 1: Axial non contrast CT Shows hemorrhagic infarcts with perilesional edema in bilateral thalami. Note the 
thrombosed hyperdense internal cerebral veins bilaterally & the thrombosed hyperdense straight sinus. Mild dilatation 
of lateral ventricle is noted.
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for 96 hours followed by oral warfarin. Persistent 
hydrocephalus required external ventricular drainage. 
The literature regarding the use of recombinant tPA in 
pediatric patients with acute ischemic stroke is limited to 
observational data. In nationwide inpatient samples, out 
of 2904 pediatric ischemic strokes only 1.6% of cases 
received intravenous and / or intra-arterial thrombolysis. 
Out of 46, 24 received only intravenous recombinant 
tPA (8). Similarly, registry by the International Pediatric 
Stroke Study (IPSS) group reported use of thrombolysis 
in 15(2.2%) cases among 687 ischemic strokes from 
2003 to 2007(9). For 7 of the 9 cases in the IPSS registry 
receiving intravenous-only recombinant tPA varied 
substantially from the standard adult regimen of 0.9 mg/
CVST in children. In adults, intravenous recombinant 
tPA is approved therapy and it is effective in reducing 
disability (5) In children for acute ischemic stroke, no 
established treatment is available. American Heart 
Association Guidelines recommend tPA can be used in 
some children with CVST (6). 
In children and adults there are no randomized control 
studies on thrombolysis (7), thrombectomy, or surgical 
decompression in CVST. These procedures have been 
used in isolated cases or small series in seriously ill 
patients (7). Tissue plasminogen activator was planned 
in view of low Glasgow coma scale and neuroimaging 
showing extensive venous thrombosis. The child 
received tPA for 36 hrs with un-fractionated heparin 
Fig 2a: T2W axial image shows mixed signal intensity lesions in bilateral thalami.
Fig 2b: GRE axial images show the blooming of the thalamic hemorrhage
Fig 2c: Sagittal view of TOF MR venogram shows non filling of the deep venous system, except for a small segment 
of the straight sinus.
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kg at less than 4.5 hours; 3 patients were treated at 5.5, 
20, and 52 hours from symptom onset and 4 received 
alternate dosing. Only 7 of 15 (47%) thrombolysis cases 
in the IPSS had favorable outcomes, with mild or no 
deficits at 90 days (6). 
There has been no report in children to the best of 
our knowledge who received tPA in CSVT due to 
homocysteinuria with complete recovery. An absolute 
indication for tPA in CVST in children is not described. 
We suggest that tPA may be considered in children 
with CVST with homocysteinuria. 
In conclusions, outcome in our child with recombinant 
tPA in cerebral venous thrombosis with homocysteinuria 
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Fig 3: Axial non contrast CT post thrombolysis shows resolution of hyperdensity in the internal cerebral vein & 
the straight sinus. The thalamic hemorrhage is resolving. External ventricular drain is noted in the right frontal horn 
decompressing the ventricular system.
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